Alzamend Neuro embarks on Phase II trial for AL001, aiming to transform lithium treatment and enhance outcomes for millions with mental health disorders.
newsletter
Subscribe to our Newsletter
Stay informed with the latest breaking news, videos, and top stories in world news, business, politics, health, and technology.
